Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Rhythm Pharmaceuticals Inc
Other Liabilities
Rhythm Pharmaceuticals Inc
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
Other Liabilities
$35.5m
|
CAGR 3-Years
146%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
24%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$6.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
See Also
What is Rhythm Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
35.5m
USD
Based on the financial report for Mar 31, 2024, Rhythm Pharmaceuticals Inc's Other Liabilities amounts to 35.5m USD.
What is Rhythm Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
60%
Over the last year, the Other Liabilities growth was 1 381%. The average annual Other Liabilities growth rates for Rhythm Pharmaceuticals Inc have been 146% over the past three years , 60% over the past five years .